Christine Brzostowski

Christine Brzostowski is a highly experienced Principal Scientist at Frontage Laboratories, Inc. since March 2020, bringing over 20 years of expertise in in-vivo and in-vitro laboratory work within pharmacokinetics and drug metabolism (PPDM). With a specialization in human ADME and proficiency in handling C14 and 3H radiolabeled compounds, Christine serves as a crucial liaison between DMPK and Clinical groups, focusing on radioactivity handling, processing, and sample analysis. Prior to Frontage Laboratories, Christine held various scientific roles at Merck and Merck Research Labs, as well as positions at SPRI and Huntingdon Life Sciences. Christine earned a Bachelor of Science degree in Small Animal Science from Delaware Valley University between 1997 and 2001.